Bartlett & Co Wealth Management’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$43.2K Sell
1,013
-306
-23% -$16.6K ﹤0.01% 771
2026
Q1
$75K Buy
1,319
+9
+0.7% +$720 ﹤0.01% 617
2025
Q4
$125K Buy
1,310
+332
+34% +$32.5K ﹤0.01% 518
2025
Q3
$95.5K Buy
978
+51
+6% +$5.28K ﹤0.01% 564
2025
Q2
$99.6K Sell
927
-95
-9% -$9.61K ﹤0.01% 544
2025
Q1
$103K Sell
1,022
-316
-24% -$31.8K ﹤0.01% 542
2024
Q4
$120K Hold
1,338
﹤0.01% 516
2024
Q3
$112K Hold
1,338
﹤0.01% 528
2024
Q2
$103K Buy
1,338
+31
+2% +$2.27K ﹤0.01% 538
2024
Q1
$89.5K Buy
1,307
+59
+5% +$3.79K ﹤0.01% 578
2023
Q4
$70.2K Hold
1,248
﹤0.01% 636
2023
Q3
$65.9K Buy
1,248
+758
+155% +$39.8K ﹤0.01% 610
2023
Q2
$26.5K Hold
490
﹤0.01% 770
2023
Q1
$24.5K Hold
490
﹤0.01% 680
2022
Q4
$22.7K Hold
490
﹤0.01% 702
2022
Q3
$19K Sell
490
-49
-9% -$1.97K ﹤0.01% 715
2022
Q2
$20.1K Buy
539
+217
+67% +$8.83K ﹤0.01% 739
2022
Q1
$14.3K Buy
+322
New +$14K ﹤0.01% 780
2021
Q4
Sell
-322
Closed -$14K 469
2021
Q3
$14K Sell
322
-33
-9% -$1.46K ﹤0.01% 670
2021
Q2
$15.2K Hold
355
﹤0.01% 653
2021
Q1
$13.7K Hold
355
﹤0.01% 702
2020
Q4
$12.8K Buy
355
+33
+10% +$1.19K ﹤0.01% 707
2020
Q3
$12.3K Hold
322
﹤0.01% 663
2020
Q2
$11.3K Hold
322
﹤0.01% 667
2020
Q1
$10.5K Hold
322
﹤0.01% 654
2019
Q4
$14.6K Hold
322
﹤0.01% 690
2019
Q3
$13.1K Buy
+322
New +$13.6K ﹤0.01% 707
2019
Q2
Sell
-27
Closed -$1.04K 772
2019
Q1
$1.04K Buy
+27
New +$1.03K ﹤0.01% 680

Other funds holding BSX

Bartlett & Co Wealth Management's BSX Position: Q2 2026 in Review

Bartlett & Co Wealth Management reduced its Boston Scientific (BSX) stake by 23% in Q2 2026, selling an estimated $16.6K and leaving 1,013 shares worth $43.2K. The position accounts for ﹤0.01% of the portfolio, ranked #771.

Bartlett & Co Wealth Management first reported a position in BSX in Q1 2019 and has held it in 28 quarters since. The position peaked at $125K in Q4 2025. 1,470 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • Bartlett & Co Wealth Management held 1,013 shares of Boston Scientific worth $43.2K as of Q2 2026.
  • Bartlett & Co Wealth Management sold 306 Boston Scientific shares in Q2 2026, an estimated $16.6K.
  • Boston Scientific made up ﹤0.01% of Bartlett & Co Wealth Management's portfolio in Q2 2026, its #771 holding.
  • Bartlett & Co Wealth Management first reported a position in Boston Scientific in Q1 2019 and has held it in 28 quarters since.
  • Bartlett & Co Wealth Management's Boston Scientific position peaked at $125K in Q4 2025.
  • 1,470 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Bartlett & Co Wealth Management's 13F filing for Q2 2026, filed 24 Jul 2026.